Related Experiment Video

Updated: Jul 6, 2026

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings
06:59

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings

Published on: November 9, 2016

Tertiary pediatric emergency department admission rates fall as waiting times increase

Damian Roland1, Gary Geelhoed

  • 1Emergency Department, Leicester Royal Infirmary, Leicester UK and Emergency Department, Princess Margaret Hospital for Children, Perth, Australia. damos@doctors.net.uk

Pediatric Emergency Care
|March 19, 2008
PubMed

Insights

Children with lower acuity triage scores in paediatric emergency departments are not more likely to be admitted if they wait longer than recommended. This reassuring finding suggests longer waits do not increase admission rates for these patients.

Area of Science:

  • Pediatric Emergency Medicine
  • Healthcare Operations Research

Background:

  • Emergency departments face challenges managing patient flow.
  • Understanding the impact of wait times on clinical outcomes is crucial for resource allocation and patient safety.

Purpose of the Study:

  • To investigate the relationship between extended wait times and hospital admission rates for children with similar triage categories.
  • To determine if prolonged waits influence the likelihood of admission for pediatric patients in lower acuity categories.

Main Methods:

  • Retrospective analysis of a 7-year period in a tertiary pediatric emergency department.
  • Comparison of admission rates for children with lower acuity triage scores (categories 3 and 4) based on wait times: within recommended time, up to twice recommended, and over twice recommended.

Main Results:

  • Children in groups experiencing waits up to or exceeding twice the recommended time were less likely to be admitted compared to those seen within the recommended time (P < 0.005).
  • This trend was consistent across individual diagnostic groups for triage categories 3 and 4.

Conclusions:

  • Extended wait times beyond recommendations do not increase hospital admission rates for children with lower acuity triage scores.
  • Patients experiencing longer waits are not inherently a different subset in terms of age or diagnosis.
  • Further research is needed to identify characteristics of children who can safely wait longer without risk of deterioration.
Abstract

More Related Videos

A Modified Sonographic Algorithm for Image Acquisition in Life-Threatening Emergencies in the Critically Ill Newborn11:27

A Modified Sonographic Algorithm for Image Acquisition in Life-Threatening Emergencies in the Critically Ill Newborn

Published on: April 7, 2023

Related Concept Videos

Tertiary Healthcare System01:21

Tertiary Healthcare System

Specialized care provided over an extended period is called tertiary care. Usually, a primary or secondary care physician will refer a patient to tertiary care. A patient's maximum physical and mental function is restored in tertiary care, which is caused due to the impact of a chronic illness or condition. Tertiary care aims to achieve the highest level of functioning possible while managing chronic illness. For example, a patient who falls and fractures their hip will need secondary care to...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...